The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Pethő, Á. G.,
Nagy, Z.,
Mezei, Z. A.,
Takács, I.,
Demeter, J.:
Béta-thalassaemia, B12-vitamin-hiány és társuló komplementmediált hemolízis.
Orv. hetil. 164 (24), 954-960, 2023.
Singh, P.,
Széles, M.,
Mezei, Z. A.,
Baráth, S.,
Hevessy, Z.:
Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, [gamma][delta] T cells, and mucosa-associated invariant T cells.
GeroScience. 44 (4), 2047-2060, 2022.
Baráth, S.,
Mezei, Z. A.,
Széles, M.,
Hevessy, Z.:
Combined use of different antibody clones improves the efficiency of human leukocyte antigen B27 detection by flow cytometry.
Cytom. Part B-Clin. Cytom. 102 (3), 239-245, 2022.
Singh, P.,
Széles, M.,
Mezei, Z. A.,
Baráth, S.,
Hevessy, Z.:
Gender-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant NKT cells, [gamma] [delta] T cells, and mucosa-associated invariant T cells.
J. Leukoc. Biol. 112 (5), 1155-1165, 2022.
Bereczky, Z.,
Gindele, R.,
Fiatal, S.,
Speker, M.,
Miklós, T.,
Balogh, L.,
Mezei, Z. A.,
Szabó, Z.,
Ádány, R.:
Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7, 1-15, (article identifier: 617711), 2021.
Koczok, K.,
Horváth, L.,
Korade, Z.,
Mezei, Z. A.,
P. Szabó, G.,
Porter, N. A.,
Kovács, E.,
Mirnics, K.,
Balogh, I.:
Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Biomolecules. 11 (8), 1-11, (article identifier: 1228), 2021.
Szántó, K.,
Mezei, Z. A.,
Kata, D.,
Földesi, I.,
Nyári, T.,
Fábián, A.,
Rutka, M.,
Bor, R.,
Bálint, A.,
Milassin, Á.,
Szepes, Z.,
Nagy, F.,
Palatka, K.,
Farkas, K.,
Molnár, T.:
Combination therapy with anti-TNFs and thiopurines does affect drug metabolite levels but it is not associated with body composition in inflammatory bowel disease patients: a cross-sectional study.
Gasztroenterol. Hepatol. Szle. 7 (4), 164-170, 2021.
Mezei, Z. A.,
Tornai, D.,
Földesi, R.,
Madar, L.,
Sümegi, A.,
Papp, M.,
Antal-Szalmás, P.:
A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation: testing several different ITD sequences and rates, simultaneously.
J. Biotechnol. 303, 25-29, 2019.
Szántó, K.,
Szíjártó, A.,
Kata, D.,
Földesi, I.,
Mezei, Z. A.,
Fábián, Á. I.,
Bálint, A.,
Bor, R.,
Farkas, K.,
Milassin, Á.,
Rutka, M.,
Szepes, Z.,
Nagy, F.,
Bubán, T.,
Lovas, S.,
Palatka, K.,
Molnár, T.:
Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre.
J. Crohns Colitis. 13 (Supplement1), S456, 2019.
Bagoly, Z.,
Székely, E.,
Kovács, K. R.,
Mezei, Z. A.,
Katona, É.,
Kappelmayer, J.,
Csiba, L.,
Muszbek, L.:
The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, (article identifier: 3), 2013.
